Download 
|
< Back |
| 03:38 PM | |
| Solara Active Pharma Sciences Limited has informed the Exchange regarding the following items approved at the Board Meeting held on November 05, 2025: 1. Appointment of Mr. Sarat Kumar Asuri, CFO as the Chief Investor Relations Officer. 2. Change in remuneration of the Whole Time Director, Mr. Mohan Muthunarayanan. 3. Change in the remuneration of the eligible Senior Management Personnels. 4. Review and confirmation of Risk Management Policy. | |
| View all announcements for Solara Active Pharma Sciences Ltd | Source: BSE India |
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback